Advocacy | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks to David Gaugh (AAM), Jessica Daley (Premier Inc) and Steven Schondelmeyer (University of Minnesota).

Advocacy

Speak Up for Access

Health care is an issue we all care about, and all of us—and those we love—will need medicine one day. AAM encourages voters and patients like you to advocate at the federal and state level for accessible prescription drugs. Your voice and your stories make a difference to policymakers and regulators.

Various topics rise and fall in prominence from season to season, but the core principles remain: improving access, maintaining affordability and ensuring a robust supply chain. Generic and biosimilar drugs are driving savings. Read more about the impact AAM is having for American patients.

View AAM's Policy Solutions

Trade

AAM promotes and protects access to affordable medicines in trade agreements and represents these interests before the U.S. Trade Representative, the Department of Commerce, Congress, The White House and other stakeholders.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.